Key result
The APOA5 rs651821 'CC' genotype was associated with a significantly higher risk of hyperlipidemic acute pancreatitis compared to 'TC+TT' genotypes (OR 8.217; 95% CI 1.023-66.01; p=0.046).
Why the study?
Although the APOA5 rs651821 locus associates with serum triglyceride levels in the Chinese population, its association with hyperlipidemic acute pancreatitis risk had not been studied.
Does the APOA5 gene variant rs651821 increase the risk of hyperlipidemic acute pancreatitis in a Chinese population?
Case-Control (n=88)
Does the APOA5 gene variant rs651821 increase the risk of hyperlipidemic acute pancreatitis in a Chinese population?
Odds Ratio: 8.217 (95% CI 1.023–66.01)
p-value: p=0.046
The 'CC' genotype of the APOA5 gene variant rs651821 is associated with a significantly increased risk of hyperlipidemic acute pancreatitis in a Southeastern Chinese population.
Should not yet alter clinical management; hypothesis-generating for APOA5 rs651821 in pancreatitis risk.
Background: Apolipoprotein A5 (APOA5) is involved in serum triglyceride (TG) regulation. Several studies have reported that the rs651821 locus in the APOA5 gene is associated with serum TG levels in the Chinese population. However, no research has been performed regarding the association between the variants of rs651821 and the risk of hyperlipidemic acute pancreatitis (HLAP). Methods: A case-control study was conducted and is reported following the STROBE guidelines. We enrolled a total of 88 participants in this study (60 HLAP patients and 28 controls). APOA5 was genotyped using PCR and Sanger sequencing. Logistic regression models were conducted to calculate odds ratios and a 95% confidence interval. Results: The genotype distribution of the rs651821 alleles in both groups follow the Hardy-Weinberg distribution. The frequency of the “C” allele in rs651821 was increased in HLAP patients compared to controls. In the recessive model, subjects with the “CC” genotype had an 8.217-fold higher risk for HLAP (OR = 8.217, 95% CI: 1.023-66.01, p = 0.046) than subjects with the “TC+TT” genotypes. After adjusting for sex, the association remained significant (OR = 9.898, 95% CI: 1.176-83.344, p = 0.035). Additionally, the “CC” genotype was related to an increased TG/apolipoprotein B (APOB) ratio and fasting plasma glucose (FPG) levels. Conclusions: Our findings suggest that the C allele of rs651821 in APOA5 increases the risk of HLAP in persons from Southeastern China.
No takes yet. Share an insight, caveat, or question.
Li et al. (2023) conducted a case-control in Hyperlipidemic acute pancreatitis (HLAP) (n=88). APOA5 rs651821 'CC' genotype vs. 'TC+TT' genotypes was evaluated on Risk of hyperlipidemic acute pancreatitis (OR 8.217, 95% CI 1.023-66.01, p=0.046). The APOA5 rs651821 'CC' genotype was associated with a significantly higher risk of hyperlipidemic acute pancreatitis compared to 'TC+TT' genotypes (OR 8.217; 95% CI 1.023-66.01; p=0.046).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: